KETOCONAZOLE SHAMPOO LABELING SHOULD CONTRAINDICATE USE IN CHILDREN UNDER 12
This article was originally published in The Tan Sheet
KETOCONAZOLE SHAMPOO LABELING SHOULD CONTRAINDICATE USE IN CHILDREN UNDER 12 years of age, FDA's Nonprescription Drugs and Dermatologic Drugs Advisory Committees recommended at a Feb. 16 joint meeting. Following a discussion of safety issues with ketoconazole 1% dandruff shampoo and an appropriate age restriction, the committees voted unanimously to recommend labeling that prohibits "use [of ketoconazole] in children under the age of 12" with the additional disclaimer that safety and efficacy trials have not been conducted in children.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC